Zobrazeno 1 - 10 of 150 pro vyhledávání: '"Rl, Stanfield"'
1
Immune recognition of viral antigens
Autor: Ia, Wilson, Rl, Stanfield, Da, Jewell, Jb, Ghiara, Daved Fremont, Ea, Stura
Publikováno v: Europe PubMed Central
The response exhibited by the immune system to viral and other foreign antigens consists of antibody-mediated and T cell-mediated immunity. Structural and molecular biological studies have shown that the antibody response is tailored to provide exqui
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::97d132cd7a1edb7818e575fda48abb3a
http://europepmc.org/abstract/med/7812653
Zobrazit plný text záznamu
2
Akademický článek
Immunization of cows with HIV envelope trimers generates broadly neutralizing antibodies to the V2-apex from the ultralong CDRH3 repertoire.
Autor: Altman PX; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America., Ozorowski G; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Stanfield RL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Haakenson J; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, United States of America.; Applied Biomedical Science Institute, San Diego, California, United States of America., Appel M; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America., Parren M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Lee WH; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Sang H; Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medical, Kansas State University, Manhattan, Kansas, United States of America., Woehl J; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America., Saye-Francisco K; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Sewall LM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Joyce C; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America., Song G; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America., Porter K; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America., Landais E; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America., Andrabi R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., Wilson IA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, United States of America., Ward AB; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Mwangi W; Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medical, Kansas State University, Manhattan, Kansas, United States of America., Smider VV; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California, United States of America.; Applied Biomedical Science Institute, San Diego, California, United States of America., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, Massachusetts, United States of America., Sok D; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America.; Global Health Investment Corporation, New York, New York, United States of America.
Publikováno v: PLoS pathogens [PLoS Pathog] 2024 Sep 09; Vol. 20 (9), pp. e1012042. Date of Electronic Publication: 2024 Sep 09 (Print Publication: 2024).
Zobrazit plný text záznamu
3
Akademický článek
Mispacking of the F87 sidechain drives aggregation-promoting conformational fluctuations in the subunit interfaces of the transthyretin tetramer.
Autor: Sun X; Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, California, USA., Ferguson JA; Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, California, USA., Yang K; Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, California, USA., Stanfield RL; Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, California, USA., Dyson HJ; Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, California, USA., Wright PE; Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, California, USA.
Publikováno v: Protein science : a publication of the Protein Society [Protein Sci] 2024 Sep; Vol. 33 (9), pp. e5101.
Zobrazit plný text záznamu
4
A tale of two fusion proteins: understanding the metastability of human respiratory syncytial virus and metapneumovirus and implications for rational design of uncleaved prefusion-closed trimers.
Autor: Lee YZ; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, USA., Han J; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, USA., Zhang YN; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, USA., Ward G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, USA., Gomes KB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, USA., Auclair S; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, USA., Stanfield RL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, USA., He L; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, USA., Wilson IA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, USA.; Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037, USA., Zhu J; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, USA.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California 92037, USA.
Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Mar 08. Date of Electronic Publication: 2024 Mar 08.
Zobrazit plný text záznamu
5
Akademický článek
Synthetic development of a broadly neutralizing antibody against snake venom long-chain α-neurotoxins.
Autor: Khalek IS; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI, New York, NY 10004, USA., Senji Laxme RR; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Evolutionary Venomics Lab, Centre for Ecological Sciences, Indian Institute of Science, Bangalore 560012, Karnataka, India., Nguyen YTK; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA., Khochare S; Evolutionary Venomics Lab, Centre for Ecological Sciences, Indian Institute of Science, Bangalore 560012, Karnataka, India., Patel RN; Centre for Snakebite Research & Interventions, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Woehl J; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI, New York, NY 10004, USA., Smith JM; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI, New York, NY 10004, USA., Saye-Francisco K; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA., Kim Y; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI, New York, NY 10004, USA., Misson Mindrebo L; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI, New York, NY 10004, USA., Tran Q; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI, New York, NY 10004, USA., Kędzior M; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI, New York, NY 10004, USA., Boré E; Centre for Snakebite Research & Interventions, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Limbo O; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI, New York, NY 10004, USA., Verma M; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI, New York, NY 10004, USA., Stanfield RL; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA., Menzies SK; Centre for Snakebite Research & Interventions, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Ainsworth S; Centre for Snakebite Research & Interventions, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Harrison RA; Centre for Snakebite Research & Interventions, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Burton DR; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA 02139, USA., Sok D; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI, New York, NY 10004, USA.; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA 92037, USA., Wilson IA; Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.; Skaggs Institute for Chemical Biology, Scripps Research Institute, La Jolla, CA 92037, USA., Casewell NR; Centre for Snakebite Research & Interventions, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK., Sunagar K; Evolutionary Venomics Lab, Centre for Ecological Sciences, Indian Institute of Science, Bangalore 560012, Karnataka, India., Jardine JG; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.; IAVI, New York, NY 10004, USA.
Publikováno v: Science translational medicine [Sci Transl Med] 2024 Feb 21; Vol. 16 (735), pp. eadk1867. Date of Electronic Publication: 2024 Feb 21.
Zobrazit plný text záznamu
6
Akademický článek
Probing the Dissociation Pathway of a Kinetically Labile Transthyretin Mutant.
Autor: Sun X; Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States., Ferguson JA; Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States., Leach BI; Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States., Stanfield RL; Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States., Dyson HJ; Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States., Wright PE; Department of Integrative Structural and Computational Biology and Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Publikováno v: Journal of the American Chemical Society [J Am Chem Soc] 2024 Jan 10; Vol. 146 (1), pp. 532-542. Date of Electronic Publication: 2023 Dec 22.
Zobrazit plný text záznamu
7
Akademický článek
The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2.
Autor: Huang R; Applied Biomedical Science Institute, San Diego, CA 92127., Warner Jenkins G; Applied Biomedical Science Institute, San Diego, CA 92127., Kim Y; College of Veterinary Medicine, Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 66506., Stanfield RL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037., Singh A; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037., Martinez-Yamout M; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037., Kroon GJ; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037., Torres JL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037., Jackson AM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037., Kelley A; Applied Biomedical Science Institute, San Diego, CA 92127., Shaabani N; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037., Zeng B; OmniAb Inc., Emeryville, CA 94608., Bacica M; Ligand Pharmaceuticals, San Diego, CA 92121., Chen W; Ligand Pharmaceuticals, San Diego, CA 92121., Warner C; Ligand Pharmaceuticals, San Diego, CA 92121., Radoicic J; Ligand Pharmaceuticals, San Diego, CA 92121., Joh J; School of Medicine, Department of Medicine, University of Louisville, Louisville, KY 40202., Dinali Perera K; College of Veterinary Medicine, Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 66506., Sang H; College of Veterinary Medicine, Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 66506., Kim T; College of Veterinary Medicine, Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 66506., Yao J; College of Veterinary Medicine, Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 66506., Zhao F; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037., Sok D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037., Allen J; Ligand Pharmaceuticals, San Diego, CA 92121., Harriman W; OmniAb Inc., Emeryville, CA 94608., Mwangi W; College of Veterinary Medicine, Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 66506., Chung D; School of Medicine, Department of Microbiology and Immunology, University of Louisville, Louisville, KY 40202., Teijaro JR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037., Dyson HJ; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037., Wright PE; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.; The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037., Wilson IA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.; The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037., Chang KO; College of Veterinary Medicine, Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS 66506., McGregor D; Applied Biomedical Science Institute, San Diego, CA 92127., Smider VV; Applied Biomedical Science Institute, San Diego, CA 92127.; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.
Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Sep 26; Vol. 120 (39), pp. e2303455120. Date of Electronic Publication: 2023 Sep 18.
Zobrazit plný text záznamu
8
Akademický článek
Divergent Total Synthesis and Characterization of Maxamycins.
Autor: Moore MJ, Qin P, Keith DJ, Wu ZC, Jung S, Chatterjee S, Tan C, Qu S, Cai Y, Stanfield RL, Boger DL
Publikováno v: Journal of the American Chemical Society [J Am Chem Soc] 2023 Jun 14; Vol. 145 (23), pp. 12837-12852. Date of Electronic Publication: 2023 Jun 06.
Zobrazit plný text záznamu
9
Akademický článek
Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins.
Autor: Misson Mindrebo L; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; International AIDS Vaccine Initiative, New York, NY 10004., Liu H; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037., Ozorowski G; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037., Tran Q; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; International AIDS Vaccine Initiative, New York, NY 10004., Woehl J; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; International AIDS Vaccine Initiative, New York, NY 10004., Khalek I; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; International AIDS Vaccine Initiative, New York, NY 10004., Smith JM; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; International AIDS Vaccine Initiative, New York, NY 10004., Barman S; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037., Zhao F; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037., Keating C; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037., Limbo O; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; International AIDS Vaccine Initiative, New York, NY 10004., Verma M; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; International AIDS Vaccine Initiative, New York, NY 10004., Liu J; Department of Bioengineering, Stanford University, Stanford, CA 94305., Stanfield RL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037., Zhu X; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037., Turner HL; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037., Sok D; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; International AIDS Vaccine Initiative, New York, NY 10004.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037., Huang PS; Department of Bioengineering, Stanford University, Stanford, CA 94305., Burton DR; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037.; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA 02139., Ward AB; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA 92037., Wilson IA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.; Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037., Jardine JG; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037.; International AIDS Vaccine Initiative, New York, NY 10004.
Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2023 Jun 13; Vol. 120 (24), pp. e2216612120. Date of Electronic Publication: 2023 Jun 05.
Zobrazit plný text záznamu
10
Akademický článek
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer.
Autor: van Schooten J; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands., Schorcht A; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands., Farokhi E; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Umotoy JC; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands., Gao H; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America., van den Kerkhof TLGM; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands., Dorning J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America., Rijkhold Meesters TG; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands., van der Woude P; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands., Burger JA; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands., Bijl T; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands., Ghalaiyini R; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands., Torrents de la Peña A; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Turner HL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Labranche CC; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America., Stanfield RL; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Sok D; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative, New York, New York, United States of America., Schuitemaker H; Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands., Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, California, United States of America.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America., Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, California, United States of America., Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America., Wilson IA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, California, United States of America.; The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California, United States of America., Sanders RW; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, California, United States of America.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, California, United States of America., van Gils MJ; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v: PLoS pathogens [PLoS Pathog] 2022 Nov 17; Vol. 18 (11), pp. e1010945. Date of Electronic Publication: 2022 Nov 17 (Print Publication: 2022).
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje